Re: "cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.

Gynecologic Oncology

Volumn 125, Issue 1, 2012, Pages 279-281

  Ansaloni, Luca ^a   De Iaco, Pierandrea ^b   Frigerio, Luigi ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cytoreductive surgery; Epithelial ovarian cancer; Hyperthermic intraperitoneal chemotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; PACLITAXEL;

ADJUVANT THERAPY; ADVANCED CANCER; ANASTOMOSIS; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CHEMOSENSITIVITY; COMORBIDITY; CYTOREDUCTIVE SURGERY; DISEASE COURSE; EPITHELIUM; FATALITY; HUMAN; HYPERTHERMIC THERAPY; ILEOSTOMY; INCIDENCE; INTENSIVE CARE UNIT; ITALY; LETTER; MINIMAL RESIDUAL DISEASE; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PELVIS ABSCESS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGEON; TUMOR CELL;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 84858334402     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.01.001     Document Type: Letter

References (8)

1. M. Deraco, S. Kusamura, S. Virzì, F. Puccio, A. Macrì, C. Famulari, M. Solazzo, S. Bonomi, D.R. Iusco, and D. Baratti Cytoreductive surgery and hyperthermicintraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial Gynecol Oncol 122 2011 215 220
2. S. Tangjitgamol, S. Manusirivithaya, M. Laopaiboon, and P. Lumbiganon Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review Gynecol Oncol 112 2009 257 264
3. C.G. Gerestein, G.M. Nieuwenhuyzen-de Boer, M.J. Eijkemans, G.S. Kooi, and C.W. Burger Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer Eur J Cancer 46 2010 102 109
4. T.C. Chua, G. Robertson, W. Liauw, R. Farrell, T.D. Yan, and D.L. Morris Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 2009 1637 1645
5. I. Vergote, C.G. Tropé, F. Amant, G.B. Kristensen, T. Ehlen, N. Johnson, R.H. Verheijen, M.E. van der Burg, A.J. Lacave, P.B. Panici, G.G. Kenter, A. Casado, C. Mendiola, C. Coens, L. Verleye, G.C. Stuart, S. Pecorelli, N.S. Reed European Organization for Researchand Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N Engl J Med 363 2010 943 953
6. M. Markman Hyperthermicintraperitoneal chemotherapy in the management ofovarian cancer: a critical need for an evidence-based evaluation Gynecol Oncol 113 2009 4 5
7. T.C. Chua, W. Liauw, G. Robertson, and D.L. Morris Establishing evidence for change in ovarian cancer surgery-proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis Gynecol Oncol 115 2009 166 168
8. J.M. Classe, M. Muller, J.S. Frenel, D.B. Rigaud, G. Ferron, and L. Gladieff La chimiotherapie intraperitoneale dans les cancers de l'ovaire. [Intra peritoneal chemotherapy in the treatment of advanced ovarian cancer] Mem Acad Natl Chir 8 2009 86 90